Bayer

Bayer completed its acquisition of Monsanto, a leading agricultural company, for $63 billion. This acquisition aimed to create a global leader in agriculture, combining Bayer's crop science business with Monsanto's expertise in seeds and traits.

Bayer celebrated its 150th anniversary, marking a century and a half of innovation and growth. The company reflected on its history and achievements while looking forward to future advancements in health and agriculture.

Bayer acquired Schering AG, a leading pharmaceutical company, for approximately €17 billion. This acquisition strengthened Bayer's position in the pharmaceutical industry, particularly in the areas of oncology and women's health.

Bayer voluntarily withdrew Baycol, a cholesterol-lowering drug, from the market due to safety concerns. This event highlighted the challenges pharmaceutical companies face in ensuring drug safety and had significant financial implications for Bayer.

Bayer acquired Miles Laboratories, an American company known for its healthcare products, including Alka-Seltzer. This acquisition expanded Bayer's presence in the United States and diversified its product offerings.

Bayer introduced Ciprofloxacin, a broad-spectrum antibiotic that became one of the most important drugs in treating bacterial infections. This further solidified Bayer's position as a leader in pharmaceutical innovation.

After World War II, IG Farben was dissolved, and Bayer was re-established as an independent company. This marked a new era for Bayer, allowing it to rebuild and expand its operations in the post-war economy.

Bayer became part of IG Farben, a conglomerate of German chemical companies. This merger was aimed at consolidating resources and research capabilities, making IG Farben one of the largest chemical companies in the world at the time.

Bayer introduced Aspirin, a revolutionary pain-relief medication, which became one of the most widely used drugs in the world. The development of Aspirin marked a significant milestone in Bayer's history, establishing its reputation as a leader in pharmaceuticals.

Bayer AG was founded by Friedrich Bayer and Johann Friedrich Weskott in Barmen, Germany. Initially, the company focused on the production of synthetic dyes. This marked the beginning of Bayer's journey as a major player in the chemical and pharmaceutical industries.